BICO Group AB (publ) (FRA:49Z)
Germany · Delayed Price · Currency is EUR | Market Cap | 108.87M -55.9% |
| Revenue (ttm) | 138.35M -13.3% |
| Net Income | -100.62M |
| EPS | -1.43 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 190 |
| Open | 1.613 |
| Previous Close | 1.582 |
| Day's Range | 1.613 - 1.613 |
| 52-Week Range | 1.469 - 3.682 |
| Beta | n/a |
| RSI | 50.99 |
| Earnings Date | Apr 29, 2026 |
About BICO Group AB
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables... [Read more]
Financial Performance
In 2025, BICO Group AB's revenue was 1.50 billion, a decrease of -13.32% compared to the previous year's 1.73 billion. Losses were -1.09 billion, 19698.2% more than in 2024.
Financial numbers in SEK Financial StatementsNews
4 X-Factors That Could Send BICO's Stock Soaring
The outlook is bright for this pioneering company.
